Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IP6K1 | Q92551 | 19/20 | 1.00 |
| ▸ | IP6K3 | Q96PC2 | 17/20 | 1.00 |
| ▸ | IP6K2 | Q9UHH9 | 17/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 1.00 |
| ▸ | TP53 | P04637 | 1/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 1.00 |
| ▸ | MEN1 | O00255 | 2/20 | 0.78 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.78 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.78 |
| ▸ | NPC1 | O15118 | 1/20 | 0.76 |
| ▸ | POLB | P06746 | 1/20 | 0.76 |
| ▸ | RAB9A | P51151 | 1/20 | 0.76 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25989723 | 0.97 | IP6K1 (1.00) | IP6K1IP6K3IP6K2ALDH1A1TP53 | |
| SCHEMBL25990975 | 0.91 | IP6K1 (1.00) | IP6K1IP6K3IP6K2ALDH1A1TP53 | |
| SCHEMBL4027834 | 0.88 | ALDH1A1 (1.00) | IP6K1IP6K3IP6K2ALDH1A1TP53 | |
| SCHEMBL14434145 | 0.88 | IP6K1 (0.78) | IP6K1IP6K3IP6K2ALDH1A1TP53 | |
| SCHEMBL25353811 | 0.88 | IP6K1 (1.00) | IP6K1IP6K3IP6K2ALDH1A1TP53 | |
| SCHEMBL25990576 | 0.88 | IP6K1 (1.00) | IP6K1IP6K3IP6K2ALDH1A1TP53 | |
| SCHEMBL10395947 | 0.88 | IP6K1 (0.78) | IP6K1IP6K3IP6K2ALDH1A1TP53 | |
| SCHEMBL31265140 | 0.86 | IP6K1 (1.00) | IP6K1IP6K3IP6K2ALDH1A1TP53 | |
| SCHEMBL25352847 | 0.86 | IP6K1 (1.00) | IP6K1IP6K3IP6K2ALDH1A1TP53 | |
| SCHEMBL25990966 | 0.86 | IP6K1 (1.00) | IP6K1IP6K3IP6K2ALDH1A1TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180273906-A1 | MICROVESICLE AND STEM CELL COMPOSITIONS FOR THERAPEUTIC APPLICATIONS | IPS HEART | 2018-09-27 | — | — | US | claimed |
| CN-118515623-B | Substituted benzisoxazole compound and application thereof in preparation of antitumor drugs | 河北中医药大学 | 2025-04-25 | — | — | CN | disclosed |
| CN-118515623-A | Substituted benzisoxazole compound and application thereof in preparation of antitumor drugs | 河北中医药大学 | 2024-08-20 | — | — | CN | disclosed |
| WO-2023154466-A1 | ARYLBENZOISOXAZOLE COMPOUNDS AS IP6K AND IPMK INHIBITORS AND METHODS OF USE THEREOF | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2023-08-17 | — | — | WO | disclosed |
| US-20210054344-A1 | CPC EXOSOMES MIRNA373 COMBINATION THERAPIES | IPS HEART | 2021-02-25 | — | — | US | disclosed |
| US-20180273906-A1 | MICROVESICLE AND STEM CELL COMPOSITIONS FOR THERAPEUTIC APPLICATIONS | IPS HEART | 2018-09-27 | — | — | US | disclosed |
| US-4898874-A | Acetic acid derivatives of 3-aryl-2,1-benzisoxazole and esters and amides thereof | A. H. ROBINS COMPANY, INC. (US) | 1990-02-06 | — | — | US | disclosed |
| EP-0260924-A1 | Antiinflammatory derivatives of 3-aryl-2,1-benzisoxazole | A.H. ROBINS COMPANY, INCORPORATED (US) | 1988-03-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180273906-A1 | MICROVESICLE AND STEM CELL COMPOSITIONS FOR THERAPEUTIC APPLICATIONS | EXOSC9, EXOSC5, EXOSC4 | IP6K1 3520/4885IP6K3 3579/4885IP6K2 3456/4885 |
| US-20210054344-A1 | CPC EXOSOMES MIRNA373 COMBINATION THERAPIES | EXOSC5, UTRN, EXOSC4 | IP6K1 3069/4885IP6K3 2790/4885IP6K2 2871/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.